glp 1 anesthesia guidelines Holding GLP-1 Agonists Prior to Elective Procedures GLP-1 and Anesthesia: Considerations and
Description
About 2% who were on 15 mg of tirzepatide had no weight loss or even gained weight and were deemed non-responders, which might be related to individual hypothalamic feedback pathway [9]
After all, people with obesity have more muscle mass than people without obesity (because their bodies carry more weight), so it's normal to lose muscle when you lose weight whether by diet, exercise, medications, or surgery
Some users with severe side effects from these GLP-1 drugs have reported vision loss, multiple trips to the ER, corrective surgeries, depression, and other serious consequences
Chinas growing middle-class urban population represents an estimated 120 million commercially addressable obesity treatment patients
PMID: 41552827
Administration Guidance Detailed instructions and support are provided to ensure you can use your medication safely and effectively
